iShares iBonds Dec 2024 Term Corporate ETF Reaches New 1-Year High – Time to Buy?

The iShares iBonds Dec 2024 Term Corporate ETF (NYSEARCA:IBDP) has recently hit a new 52-week high during trading on Friday. The stock reached a peak of $25.21 before closing at $25.20, with a trading volume of 19,203 shares. In the previous session, it had closed at $25.19.

Performance Overview of iShares iBonds Dec 2024 Term Corporate ETF

The fund's performance remains stable with a fifty-day simple moving average of $25.16 and a two-hundred-day simple moving average of $25.11. This indicates a consistent pricing trend over the short and long term.

Institutional Interest and Trading Activity

Institutional investors have been active regarding their investments in the iShares iBonds Dec 2024 Term Corporate ETF. For instance, BNP Paribas Financial Markets acquired a new stake in the ETF during the first quarter, investing approximately $118,000. Horan Securities Inc. increased its holdings by 4.3% during the same period, now owning 38,351 shares valued at roughly $961,000 after adding 1,592 shares. United Community Bank also boosted its position by 11.2%, holding 15,014 shares worth $376,000 after acquiring an additional 1,510 shares. Moreover, Gould Asset Management LLC CA grew its investment substantially by 33.6% during the first quarter, now owning 32,065 shares valued at $803,000 after purchasing 8,060 shares. Lastly, Motley Fool Wealth Management LLC raised its stake by 2.5%, now holding over 1 million shares valued at approximately $26,121,000 after acquiring an additional 25,289 shares.

Insights on iShares iBonds Dec 2024 Term Corporate ETF

The iShares iBonds Dec 2024 Term Corporate ETF primarily focuses on investment-grade fixed income securities. It tracks a global index featuring U.S. dollar-denominated investment-grade corporate bonds maturing between December 31, 2023, and January 1, 2025. Launched on March 11, 2015, IBDP is managed by BlackRock.

Considering Investment Opportunities

With the ETF reaching a new high, potential investors might question whether now is a good time to enter. Given the recent performance and institutional interest, it could be worth considering this investment as part of a diversified portfolio.

Further Reading and Insights

• Explore five stocks that might outperform the iShares iBonds Dec 2024 Term Corporate ETF
• Learn how to use a Certificate of Deposit Calculator
• Review how Lam Research exceeded analysts’ expectations with a strong earnings report
• Discover five highly-rated dividend stocks worth considering
• Analyze PureCycle's 250% growth in 2024 and whether it's still a viable investment
• Understand the implications of upcoming IPO stock lockup periods
• Catch up on MarketBeat’s week in review for the latest news

For daily news and updates on the iShares iBonds Dec 2024 Term Corporate ETF, consider subscribing for concise summaries and analysts' ratings delivered straight to your inbox.

iShares, ETF, Investment